November 9-11, 2020 | Virtual Conference


Rachel Sher, J.D., M.P.H. 

Vice President, Policy and Regulatory Affairs
National Organization for Rare Disorders

Rachel Sher serves as the Vice President of Policy and Regulatory Affairs at NORD where she oversees federal, state, and regulatory policy. Prior to joining NORD, Rachel served as Deputy General Counsel at the Association for Accessible Medicines (AAM) and as Senior Policy Analyst in the Commissioner’s Office of Policy at the Food and Drug Administration (FDA) where she acted as the FDA lead in the 21st Century Cures Act legislative process. For ten years before joining FDA, Rachel served as Senior FDA Counsel for Ranking Member (Formerly Chairman) Henry A. Waxman, on the Democratic Committee Staff for the Energy and Commerce Committee and in Representative Waxman’s personal office. She holds degrees from the University of Florida Levin College of Law (J.D.), The George Washington University School of Public Health (M.P.H.) and Duke University (B.A.).

Skip to content